Trump Announces Partnership with AstraZeneca to Reduce Drug Prices
From CNN — Oct 15th, 2025
President Donald Trump announced a deal with AstraZeneca aimed at lowering drug costs through “Most Favored Nation” pricing — following a similar agreement with Pfizer. Both drugmakers agreed to sell select medications at discounted rates and join the new TrumpRx online platform, offering direct-to-consumer discounts.
While the White House touts the move as a win for affordability, experts question whether it will bring meaningful relief. “If the White House is appeased by these deals, it’s less likely they will take aggressive regulatory or administrative actions,” said Spencer Perlman, director of health care policy research at Veda Partners. Perlman noted that Pfizer and AstraZeneca “won’t surrender anything of value” with most of the measures, though introducing new drugs at Most Favored Nation pricing could prove significant.
This excerpt and any accompanying media (including audio, video, or images) are shared under the principles of fair use, for informational and archival purposes only. All rights remain with the original publisher.